
Unichem Laboratories Limited has informed the Exchange about press release dated 16-Aug-2022 titled ANDA approval from United States Food and Drug Administration (USFDA) for Unichem���s Quetiapine Extended-Release Tablets USP.
Filed with NSE ·

Unichem Laboratories Limited has informed the Exchange about press release dated 16-Aug-2022 titled ANDA approval from United States Food and Drug Administration (USFDA) for Unichem���s Quetiapine Extended-Release Tablets USP.
6ix hasn’t read this filing yet.
Unichem Laboratories Limited on 6ix
Follow Unichem Laboratories into a list and get an email when it puts out news.
Follow Unichem Laboratories